Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19

INTRODUCTION: While there are no pharmacological treatments with proven efficacy for coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy. Some aspects of this therapy are still unknown, including the optimal timing of administration. OBJECTIVE: This observational stud...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Hosp Pharm
Main Authors: Moreno Diaz, Raquel, Amor García, Miguel Angel, Teigell Muñoz, Francisco Javier, Saldaña Perez, Leonardo Ernesto, Mateos Gonzalez, María, Melero Bermejo, Jose Antonio, López Hernández, Alberto, Reyes Marquez, Laura, De Guzman García-Monge, Maria Teresa, Perez Quero, Jose Luis, Homez Guzman, Marcela Patricia
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2022
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7907834/
https://ncbi.nlm.nih.gov/pubmed/33627476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2020-002669
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki